JPRN-UMIN000047506已完成未知
Effects of fluticasone furoate, vilanterol and umeclidinium bromide on asthma - Fluticasone furoate, vilanterol and umeclidinium bromide on asthma
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 114
研究概览
简要总结
Inhaled drugs were switched to FF/UMEC/VI 200/62.5/25 microgram for asthma patients. Peripheral and small airways were found to be dilated.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Subjects who did not agree with the participation of the study.
研究者
相似试验
招募中
3 期
The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPDCOPDNCT06474039Mahidol University50
已完成
4 期
The Clinical Effect of Monodisperse Fluticasone Propionate in AsthmaAsthmaNCT01662778Imperial College London21
撤回
不适用
Inhaled Fluticasone Propionate: Effect on Parameters of Bone Metabolism in Patients With Mild to Moderate AsthmaAsthmaNCT00409630University of Kansas
已完成
不适用
Use of Fluticasone Propionate/Salmeterol Combination Post Emergency Department VisitAsthmaNCT01332357GlaxoSmithKline6,139
已完成
3 期
A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)Pulmonary Disease, Chronic ObstructiveNCT02164513GlaxoSmithKline10,355